Research Publications

[wpdreams_ajaxsearchpro id=1]
American Society of Clinical Oncology ASCO 2021 Abstract #2621 Adverse effects of COVID-19 vaccination among cancer patients: Results from a
Read More
The COVID-19 pandemic dramatically impacted society and health care on a global scale. To capture the lived experience of patients with prostate cancer and family members/caregivers during the COVID-19 pandemic, we performed a mixed-methods study of posts to two online networks.. [ScienceDirect]
Read More
Previous epidemiological studies have examined the relationship between sleep disturbances and prostate cancer risk and/or survival 1, 2. However, less has been published about the impact of sleep disturbance on quality of life (QoL) for prostate cancer survivors and their caregivers. [By: Rebecca Robbins, Girardin Jean‐Louis, Nicholas Chanko, Penelope Combs, Nataliya Byrne, Stacy Loeb]
Read More
In drug development clinical trials, there is a need for balance between restricting variables by setting enrollment criteria and representing the more diverse patient population that may use a product once it is approved. Although recent policy initiatives focusing on inclusion of historically underrepresented groups are being implemented, barriers still remain. [by. Farris Timimi; Sara Ray; Erik Jones; Lee Aase; Kathleen Hoffman]
Read More
To refine a method of collecting the data from various patient generated data sources to explore themes with high repeatability. FDA will acquire new insight into understanding the perspectives of patients and caregivers through analyses of multiple sources. [by: Author ChristineLee, Christopher St Clair, CDR Christine Merendac, CAPT Richardae Araojo, SaraRay, DerrickBeasley, RADM Denise Hintone]
Read More
News stories represent an important source of information. We aimed to evaluate the impact of “spin” (i.e., misrepresentation of study results) in health news stories reporting studies of pharmacologic treatments on patients’/caregivers’ interpretation of treatment benefit.
Read More
Adverse drug reactions (ADRs) occur in nearly all patients on chemotherapy, causing morbidity and therapy disruptions. Detection of such ADRs is limited in clinical trials, which are underpowered to detect rare events.
Read More
Access to comparative information on hospitals’ quality of cancer care is limited. Patients’ interest in using this information when selecting a hospital for cancer surgery and the specific data they would desire are unknown. This study gauges patients’ demand for comparative information on hospitals’ quality of cancer surgery.Access to comparative information on hospitals’ quality of cancer care is limited. Patients’ interest in using this information when selecting a hospital for cancer surgery and the specific data they would desire are unknown. This study gauges patients’ demand for comparative information on hospitals’ quality of cancer surgery.
Read More
Current genetics literacy, perspectives, and experiences of cancer, chronic, and rare disease patients and caregivers Kathleen D. Hoffman, PhD, MSPH,
Read More